Meformin 500 mg (Tablet)

Unit Price: ৳ 2.00 (10 x 10: ৳ 200.00)
Strip Price: ৳ 20.00

Medicine Details

Indications

  • Treatment of type 2 diabetes mellitus
  • Management of type 2 diabetes in overweight patients
  • Monotherapy for adults with type 2 diabetes
  • Combination therapy for adults with type 2 diabetes
  • Use in children from 10 years of age and adolescents

Pharmacology

  • Biguanide type oral antihyperglycemic drug
  • Lowers basal and postprandial plasma glucose
  • Decreases hepatic glucose production
  • Improves insulin sensitivity
  • Decreases intestinal absorption of glucose

Dosage & Administration

  • Dosage individualized based on effectiveness and tolerance
  • Usual starting dose for adults - 500 mg twice a day or 850 mg once a day
  • Usual starting dose for children - 500 mg twice a day
  • Maximum recommended daily dose - 2000 mg for adults and children
  • Usual starting dose for extended release tablet - 500 mg once daily
  • Recommended storage conditions

Interaction

  • Possible interaction with Furosemide and Nifedipine
  • Potential interaction with cationic drugs and drug-induced hyperglycemia
  • No effect on Cimetidine pharmacokinetics

Contraindications

  • Hypersensitivity to the active substance
  • Severe renal failure
  • Acute metabolic acidosis
  • Acute conditions altering renal function
  • Conditions causing tissue hypoxia

Side Effects

  • Hemolytic anemia
  • Lactic acidosis
  • Vitamin B12 absorption decrease
  • Neuropathy in patients with vitamin B12 deficiency
  • Taste disturbance
  • Encephalopathy
  • Gastrointestinal disorders
  • Liver function test abnormalities or hepatitis
  • Skin reactions

Pregnancy & Lactation

  • Uncontrolled diabetes risk during pregnancy
  • Excretion into human breast milk
  • No adverse effects observed in breastfed newborns/infants
  • Limited data available for breastfeeding

Precautions & Warnings

  • Substantial excretion by the kidney
  • Risk of lactic acidosis and Meformin accumulation
  • Lowering of vitamin B12 level
  • Increased risk of hypoglycemia
  • Regular monitoring of renal function advised
  • Therapy cessation before surgery and clinical investigations

Use in Special Populations

  • Elderly dosage adjustment based on renal function
  • No effect on growth and puberty detected in controlled clinical studies
  • Caution recommended for children aged between 10 and 12 years
  • Creatinine clearance determination before initiating treatment and regularly thereafter

Overdose Effects

  • No hypoglycemia observed up to 85 gm doses
  • Lactic acidosis as a potential outcome
  • Hemodialysis as the most effective method for removal

Therapeutic Class

  • Biguanides

Storage Conditions

  • Keep below 30°C temperature
  • Protected from light & moisture
  • Keep out of the reach of children

Related Brands